EMS 6.25% 1.5¢ eastern metals limited

phase iii trials complete - data awaited, page-29

  1. 4,131 Posts.
    lightbulb Created with Sketch. 73
    Hi bluebush

    The paragraph that I like the best is this one..........Management remains confident that these confirmatory trials will support the conclusions of the Phase II trials that ArTiMist can provide a viable alternative to the commonly accepted treatment of intravenous I quinine.

    We know that phase II trials were fine and given that management will have some raw data there is confidence underlying this statement.

    kippax
 
watchlist Created with Sketch. Add EMS (ASX) to my watchlist
(20min delay)
Last
1.5¢
Change
-0.001(6.25%)
Mkt cap ! $2.728M
Open High Low Value Volume
1.5¢ 1.5¢ 1.5¢ $3.51K 234K

Buyers (Bids)

No. Vol. Price($)
1 64666 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 236320 2
Last trade - 12.06pm 22/11/2024 (20 minute delay) ?
EMS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.